213 related articles for article (PubMed ID: 8215640)
21. CD2-CD48 interactions promote interleukin-2 and interferon-gamma synthesis by stabilizing cytokine mRNA.
Musgrave BL; Watson CL; Haeryfar SM; Barnes CA; Hoskin DW
Cell Immunol; 2004 May; 229(1):1-12. PubMed ID: 15331323
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice.
Wissing KM; Desalle F; Abramowicz D; Willems F; Leo O; Goldman M; Alegre ML
Transplantation; 1999 Sep; 68(5):677-84. PubMed ID: 10507488
[TBL] [Abstract][Full Text] [Related]
23. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance.
Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ
Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
Lorré K; Fransen L; Ceuppens JL
Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
[TBL] [Abstract][Full Text] [Related]
25. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
Mottram PL; Han WR; Murray-Segal LJ; Mandel TE; Pietersz GA; McKenzie IF
Transplantation; 1997 Sep; 64(5):684-90. PubMed ID: 9311703
[TBL] [Abstract][Full Text] [Related]
26. Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor.
Levitt LJ; Nagler A; Lee F; Abrams J; Shatsky M; Thompson D
J Clin Invest; 1991 Jul; 88(1):67-75. PubMed ID: 1676038
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
[TBL] [Abstract][Full Text] [Related]
28. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S
Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434
[TBL] [Abstract][Full Text] [Related]
29. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
Stell D; Marshall H; Bradley JA; Bolton EM
Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
[TBL] [Abstract][Full Text] [Related]
30. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
[TBL] [Abstract][Full Text] [Related]
31. Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice.
Pioli C; Pucci S; Barile S; Frasca D; Doria G
Immunology; 1998 Jul; 94(3):380-7. PubMed ID: 9767421
[TBL] [Abstract][Full Text] [Related]
32. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
33. Enhanced allograft survival via simultaneous blockade of transferrin receptor and interleukin-2 receptor.
Woodward JE; Bayer AL; Baliga P
Transplantation; 1999 Nov; 68(9):1369-76. PubMed ID: 10573078
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival of mouse cardiac allografts after CD4 or CD8 monoclonal antibody therapy is associated with selective intragraft cytokine protein expression: interleukin (IL)-4 and IL-10 but not IL-2 or interferon-gamma.
Hancock W; Mottram PL; Purcell LJ; Han WR; Pietersz GA; McKenzie IF
Transplant Proc; 1993 Oct; 25(5):2937-8. PubMed ID: 8212290
[No Abstract] [Full Text] [Related]
35. Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity.
Qin L; Ding Y; Bromberg JS
Hum Gene Ther; 1996 Oct; 7(16):1981-8. PubMed ID: 8930658
[TBL] [Abstract][Full Text] [Related]
36. Induction of human monocyte IL-1 mRNA and secretion during anti-CD3 mitogenesis requires two distinct T cell-derived signals.
Landis RC; Friedman ML; Fisher RI; Ellis TM
J Immunol; 1991 Jan; 146(1):128-35. PubMed ID: 1824588
[TBL] [Abstract][Full Text] [Related]
37. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
38. Anti-transforming growth factor antibody at low but not high doses limits cyclosporine-mediated nephrotoxicity without altering rat cardiac allograft survival: potential of therapeutic applications.
Khanna AK; Plummer MS; Hilton G; Pieper GM; Ledbetter S
Circulation; 2004 Dec; 110(25):3822-9. PubMed ID: 15583082
[TBL] [Abstract][Full Text] [Related]
39. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
40. In vitro T cell unresponsiveness following low-dose injection of anti-CD3 MoAb.
Ben-Amor A; Leite-De-Moraes MC; Lepault F; Schneider E; Machavoine F; Arnould A; Chatenoud L; DY M
Clin Exp Immunol; 1996 Mar; 103(3):491-8. PubMed ID: 8608651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
